Page last updated: 2024-08-17

isosorbide dinitrate and macitentan

isosorbide dinitrate has been researched along with macitentan in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baum, C; Daiber, A; Hausding, M; Helmstädter, J; Iglarz, M; Jansen, T; Kashani, F; Kröller-Schön, S; Münzel, T; Oelze, M; Roohani, S; Schulz, E; Steven, S	1

Other Studies

1 other study(ies) available for isosorbide dinitrate and macitentan

Article	Year
The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation. Oxidative medicine and cellular longevity, 2018, Volume: 2018 Topics: Animals; Cells, Cultured; Endothelin Receptor Antagonists; Endothelium, Vascular; Humans; Inflammation; Isosorbide Dinitrate; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Pyrimidines; Rats; Rats, Wistar; Sulfonamides; Vascular Diseases; Vasodilator Agents	2018

Article

Year

The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation.

Oxidative medicine and cellular longevity, 2018, Volume: 2018

Topics: Animals; Cells, Cultured; Endothelin Receptor Antagonists; Endothelium, Vascular; Humans; Inflammation; Isosorbide Dinitrate; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Pyrimidines; Rats; Rats, Wistar; Sulfonamides; Vascular Diseases; Vasodilator Agents

2018